News & Articles
Selected Filters:
The Rise of Companion Diagnostic Tests for Personalized Cancer Treatment
A look at some of the available companion diagnostics for breast, lung and colorectal cancer
Organs May Have Own Sexual Identity
Study suggests our organs may have their own sexual identity
WaferGen Announces Key Findings from Collaborators Utilizing Company’s ICELL8™ Single-Cell System at AGBT 2016 General Meeting
Results from Genentech, Karolinska Institutet, National Jewish Health, and MD Anderson Cancer Center Highlight ICELL8™ Single-Cell System Performance
News From the Forefront of Cancer Diagnostics
SelectScience publishes breaking news from the cancer diagnostics industry
Crown Bioscience to Commercialize University of York's Prostate Cancer Models for Drug Development
Crown Bioscience to Commercialize University of York's Prostate Cancer Models for Drug Development
Sophia Genetics and Integrated DNA Technologies (IDT) Partner to Create NGS Solutions in Routine Clinical Diagnostics
Sophia Genetics announces a strategic partnership with Integrated DNA Technologies to accelerate the adoption of next generation sequencing (NGS) in routine clinical diagnostics.
GATC Biotech Offers the First Global Liquid Biopsy Service for Clinical Research and Translational Medicine
GATC Biotech Offers the First Global Liquid Biopsy Service for Clinical Research and Translational Medicine
QIAGEN Launches Targeted RNA Panels for Next-Generation Sequencing
QIAGEN Launches Targeted RNA Panels for Next-Generation Sequencing
Mayo Clinic's Dr Joseph Mikhael Discusses Evolving Multiple Myeloma Clones
Dr Joseph Mikhael addresses the delegation during the 7th International Binding Site Symposium
Illumina Forms New Company to Enable Early Cancer Detection via Blood-Based Screening
Illumina Forms New Company to Enable Early Cancer Detection via Blood-Based Screening
Lonza and Renova Therapeutics Announce Manufacturing Agreement for Clinical Supply of RT-100 Gene Therapy
Lonza and Renova Therapeutics Announce Manufacturing Agreement for Clinical Supply of RT-100 Gene Therapy
QIAGEN and 10x Genomics to Enter into Co-Marketing and Co-Development Collaboration
Multi-phase collaboration to advance next-generation sequencing, single-cell biology, and bioinformatics Sample to Insight solutions
Roche Presents Updated Results for Investigational Cancer Immunotherapy Atezolizumab in Advanced Bladder Cancer
Roche Presents Updated Results for Investigational Cancer Immunotherapy Atezolizumab in Advanced Bladder Cancer
Silicon Biosystems Menarini, Swift Biosciences Announce Collaboration and CoMarketing Partnership to Unlock Genomic Information from FFPE Samples
Alliance Combines the Power of Precise Single-Cell Isolation with Next Generation Sequencing
Dako, an Agilent Technologies Company, Announces Expanded FDA Approval of Complementary Diagnostic Test to Include Melanoma
Dako, an Agilent Technologies Company, Announces Expanded FDA Approval of Complementary Diagnostic Test to Include Melanoma
Protagen Supports Novel Route to Serum Based Prostate Cancer Diagnostics
Protagen Supports Novel Route to Serum Based Prostate Cancer Diagnostics
The Latest Cutting Edge Cancer Methods Available for Download
The SelectScience article library contains downloads on the very latest technologies being used in cancer research and diagnostics
Agena Bioscience Partners with DaRui Biotech to Bring MassARRAY Technology to the Diagnostics Market in China
Agena Bioscience Partners with DaRui Biotech to Bring MassARRAY Technology to the Diagnostics Market in China
Envigo Rat Models Proven to be Susceptible to Intra-Vaginal HSV-2 Infection and Protectable by Attenuated HSV-1 Against Symptomatic HSV-2
Scientific findings establish the effectiveness of Envigo’s new approach to investigate the protective effects of vaccine candidates and anti-viral microbodies and to study asymptomatic primary genital HSV-2 infection
Cancer Diagnostics: A 2016 Update
An overview of new developments in the field of cancer diagnostics
Rockland Immunochemicals, Inc. Introduces Melanoma Cell Lines in Collaboration with The Wistar Institute
Rockland Immunochemicals, Inc. Introduces Melanoma Cell Lines in Collaboration with The Wistar Institute